Trials / Completed
CompletedNCT03018548
Improvised Explosive Device (IED) Level Blasting of Human Blood With Slosh Prevention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To monitor changes in indicators of red cell damage such as extracellular hemoglobin, potassium (K-ABL), and lactate dehydrogenase (LD) post blast exposure.
Detailed description
Traumatic brain injury (TBI) causes significant morbidity and mortality, accompanied by high related costs. Recent hypotheses concerning the pathophysiology of TBI invoke Strain Shear Theory and Cavitation Theory. The invbestigators propose to test the importance of the latter by directing blast waves into containers that are either partially or completely filled with blood and measuring markers of lysis. These experiments are designed to better understand the demonstrated effectiveness of mild jugular compression according to the principle of the Queckenstedt Maneuver to reduce the likelihood of TBI by filling up the compliance of the cranial space. A device (C-Collar) is being developed by Q30 Labs, LLC (Q30), to accomplish this effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood draw | subjects will have blood drawn done. This blood will then be exposed to blasting with CO2 cartridge |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2017-01-12
- Last updated
- 2020-08-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03018548. Inclusion in this directory is not an endorsement.